Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Inventory (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Inventory for 13 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 5.49% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 5.49% increase, with the full-year FY2025 number at $4.8 million, up 5.49% from a year prior.
  • Inventory was $4.8 million for Q4 2025 at Ekso Bionics Holdings, down from $5.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $5.7 million in Q1 2023 to a low of $1.8 million in Q3 2021.
  • A 5-year average of $4.2 million and a median of $5.0 million in 2024 define the central range for Inventory.
  • Peak YoY movement for Inventory: decreased 19.68% in 2021, then soared 131.36% in 2022.
  • Ekso Bionics Holdings' Inventory stood at $2.2 million in 2021, then skyrocketed by 131.36% to $5.2 million in 2022, then dropped by 2.64% to $5.0 million in 2023, then decreased by 9.49% to $4.6 million in 2024, then increased by 5.49% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Inventory are $4.8 million (Q4 2025), $5.0 million (Q3 2025), and $5.4 million (Q2 2025).